Intercept Pharmaceuticals (ICPT) Prices IPO at $15 Per Share

October 11, 2012 7:03 AM EDT Send to a Friend
Intercept Pharmaceuticals, Inc., (Nasdaq: ICPT) a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the common stock is being offered by Intercept.

In addition, the underwriters have a 30-day option to purchase up to an additional 750,000 shares of common stock from Intercept. The Company's shares are expected to begin trading on The NASDAQ Global Market on Thursday, October 11, 2012 under the trading symbol (Nasdaq: ICPT).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs

Add Your Comment